RSS
Sitemap
Login (HMA-DMS)
Contact
Search
About HMA
Human Medicines
Veterinary Medicines
You are here:
Home
>
Human Medicines
>
CMDh
>
Advice from CMDh
>
Procedural advice
CMDh
About CMDh
Statistics
Agendas and Minutes
Press Releases
COVID-19
BREXIT
Nitrosamine impurities
Procedural Guidance
CMDh-Referrals
Product Information
Advice from CMDh
Procedural advice
Product-related advice
Templates
CMD Working Parties / Working Groups
Paediatric Regulation
Pharmacovigilance
Falsified Medicines
Questions & Answers
Contact Points
Recently Published history
MRI Product Index
Pharmacovigilance
Availability of Medicines
Publications and reports
National Contacts
Procedural advice
End of pilot for splitting of MRP/DCPs
(May 2020) [
Tracked]
Decisions on additional year of market protection/data exclusivity for new therapeutic indication agreed by the CMDh
(December 2022)
Monitoring of medicines originating from Japan
(September 2019)
[
Tracked
]
